Five‐year cost‐effectiveness of the Patient Empowerment Programme ( PEP ) for type 2 diabetes mellitus in primary care

Diabetes Obesity and Metabolism ◽

10.1111/dom.12919 ◽

2017 ◽

Vol 19 (9) ◽

pp. 1312-1316 ◽

Author(s):

Jinxiao Lian ◽

Sarah M. McGhee ◽

Ching So ◽

June Chau ◽

Carlos K. H. Wong ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Primary Care ◽

Type 2 Diabetes Mellitus ◽

Cost Effectiveness ◽

Patient Empowerment

Download Full-text

Long-term cost-effectiveness of a Patient Empowerment Programme for type 2 diabetes mellitus in primary care

Diabetes Obesity and Metabolism ◽

10.1111/dom.13485 ◽

2018 ◽

Vol 21 (1) ◽

pp. 73-83 ◽

Author(s):

Jinxiao Lian ◽

Sarah M. McGhee ◽

Ching So ◽

June Chau ◽

Carlos K. H. Wong ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Primary Care ◽

Type 2 Diabetes Mellitus ◽

Cost Effectiveness ◽

Patient Empowerment

Download Full-text

Effect of a structured diabetes education programme in primary care on hospitalizations and emergency department visits among people with Type 2 diabetes mellitus: results from the Patient Empowerment Programme

Diabetic Medicine ◽

10.1111/dme.12969 ◽

2015 ◽

Vol 33 (10) ◽

pp. 1427-1436 ◽

Author(s):

C. K. H. Wong ◽

W. C. W. Wong ◽

Y. F. Wan ◽

A. K. C. Chan ◽

F. W. K. Chan ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Primary Care ◽

Emergency Department ◽

Type 2 Diabetes Mellitus ◽

Diabetes Education ◽

Patient Empowerment ◽

Education Programme ◽

Emergency Department Visits

Download Full-text

Effects of Patient Empowerment Programme (PEP) on Clinical Outcomes and Health Service Utilization in Type 2 Diabetes Mellitus in Primary Care: An Observational Matched Cohort Study

PLoS ONE ◽

10.1371/journal.pone.0095328 ◽

2014 ◽

Vol 9 (5) ◽

pp. e95328 ◽

Author(s):

Carlos K. H. Wong ◽

William C. W. Wong ◽

Cindy L. K. Lam ◽

Y. F. Wan ◽

Winnie H. T. Wong ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Primary Care ◽

Type 2 Diabetes Mellitus ◽

Cohort Study ◽

Health Service ◽

Health Service Utilization ◽

Patient Empowerment ◽

Download Full-text

Patient Empowerment Programme in primary care reduced all-cause mortality and cardiovascular diseases in patients with type 2 diabetes mellitus: a population-based propensity-matched cohort study

Diabetes Obesity and Metabolism ◽

10.1111/dom.12397 ◽

2014 ◽

Vol 17 (2) ◽

pp. 128-135 ◽

Author(s):

C. K. H. Wong ◽

W. C. W. Wong ◽

Y. F. Wan ◽

A. K. C. Chan ◽

K. L. Chung ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Primary Care ◽

Type 2 Diabetes Mellitus ◽

Cohort Study ◽

Patient Empowerment ◽

Population Based ◽

Matched Cohort ◽

All Cause Mortality

Download Full-text

198 Primary care use of SGLT2 inhibitors in patients with type 2 diabetes mellitus and cardiovascular disease – are we missing a trick?

10.1136/heartjnl-2021-bcs.194 ◽

2021 ◽

Author(s):

David Higson ◽

Andrew Turley

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Primary Care ◽

Type 2 Diabetes Mellitus ◽

Sglt2 Inhibitors

Download Full-text

Cost-effectiveness of Strain-guided Sodium-Glucose Co-transporter-2 Inhibitors Treatment in Elderly People With Type 2 Diabetes Mellitus

Heart Lung and Circulation ◽

10.1016/j.hlc.2021.06.204 ◽

2021 ◽

Vol 30 ◽

pp. S185-S186

Author(s):

A. Halabi ◽

M. Nolan ◽

T. Marwick

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cost Effectiveness ◽

Download Full-text

HT3 COST-EFFECTIVENESS OF BLOOD PRESSURE LOWERING WITH A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN TYPE 2 DIABETES MELLITUS: A TRIAL-BASED ANALYSIS USING THE ADVANCE STUDY

Value in Health ◽

10.1016/s1098-3015(11)73064-9 ◽

2010 ◽

Vol 13 (7) ◽

pp. A504

Author(s):

PM Clarke ◽

P Glasziou ◽

J Alexander ◽

J Chalmers ◽

A Patel

Keyword(s):

Diabetes Mellitus ◽

Blood Pressure ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cost Effectiveness ◽

Fixed Combination ◽

Blood Pressure Lowering ◽

Advance Study ◽

Pressure Lowering

Download Full-text

The cost‐effectiveness of dapagliflozin in treating high risk patients with type 2 diabetes mellitus: an economic evaluation using data from the DECLARE‐TIMI 58 trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14308 ◽

2020 ◽

Author(s):

Phil McEwan ◽

Angharad R. Morgan ◽

Rebecca Boyce ◽

Klas Bergenheim ◽

Ingrid Gause‐Nilsson ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Economic Evaluation ◽

Cost Effectiveness ◽

High Risk ◽

Risk Patients ◽

Download Full-text

The Cost-Effectiveness OF Canagliflozin (Cana) Versus Dapagliflozin (Dapa) In Patients With Type 2 Diabetes Mellitus (T2dm) With Inadequate Control On Metformin (Met) Monotherapy In The United Kingdom

Value in Health ◽

10.1016/j.jval.2014.08.694 ◽

2014 ◽

Vol 17 (7) ◽

pp. A344 ◽

Author(s):

M. Schroeder ◽

P. Johansen ◽

G. Thompson ◽

M. Willis ◽

C. Neslusan

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

United Kingdom ◽

Cost Effectiveness ◽

The United Kingdom ◽

Download Full-text

Evaluating The Long-Term Cost-Effectiveness Of Liraglutide 1.2 Mg And Exenatide In Patients With Type 2 Diabetes Mellitus

Value in Health ◽

10.1016/j.jval.2014.08.161 ◽

2014 ◽

Vol 17 (7) ◽

pp. A744-A745

Author(s):

LW Shi ◽

S Han ◽

F LIU

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cost Effectiveness

Download Full-text